IMMUNOGEN INC 45253H101 US45253H1014 BBG00JQBF927 1/31/2024 A proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to ImmunoGen's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 814978 0 FOR 814978 FOR CARNIVAL CORPORATION 143658300 PA1436583006 BBG00QFZPKZ8 4/5/2024 To hold a (non-binding) advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 7851 0 ABSTAIN 7851 FOR BIOMARIN PHARMACEUTICAL INC 09061G101 US09061G1013 BBG000CZWZ05 5/21/2024 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 97 0 ABSTAIN 97 FOR SAREPTA THERAPEUTICS INC 803607100 US8036071004 BBG000BCJ161 6/6/2024 Advisory vote to approve, on a non-binding basis, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2619 0 ABSTAIN 2619 FOR MP MATERIALS CORP 553368101 US5533681012 BBG00TJGL0F0 6/11/2024 Advisory vote to approve compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2644983 0 ABSTAIN 2644983 FOR MERSANA THERAPEUTICS INC 59045L205 US59045L2051 BBG00Z736H31 6/11/2024 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 11547 0 ABSTAIN 11547 FOR IOVANCE BIOTHERAPEUTICS INC 462260100 US4622601007 BBG000FTLBV7 6/11/2024 To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 108383 0 ABSTAIN 108383 FOR